• 1
    IARC Working Group on the Evaluation of Cancer-Preventive Strategies; weight and weight control; colorectal cancer. In: VainioH, BiachiniF. editors. IARC handbooks of cancer prevention, vol. 6: Weight control and physical activity. Lyon: IARC Press, 2002. Chapter 5, 8595.
  • 2
    Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995; 6: 16479.
  • 3
    Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 2002; 94: 97280.
  • 4
    Renehan AG, O'Connell J, O'Halloran D, Shanahan F, Potten CS, O'Dwyer ST, Shalet SM. Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications. Horm Metab Res 2003; 35: 71225.
  • 5
    Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 2000; 21: 21544.
  • 6
    Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002; 23: 82454.
  • 7
    Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, Dobs A, Savage PJ. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999; 91: 114754.
  • 8
    Saydah SH, Platz EA, Rifai N, Pollak MN, Brancati FL, Helzlsouer KJ. Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 4128.
  • 9
    Palmqvist R, Stattin P, Rinaldi S, Biessy C, Stenling R, Riboli E, Hallmans G, Kaaks R. Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden. Int J Cancer 2003; 107: 8993.
  • 10
    Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch Jacquotte A, Shore RE, Riboli E. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000; 92: 1592600.
  • 11
    Ma J, Giovannucci E, Pollak M, Leavitt A, Tao Y, Gaziano JM, Stampfer MJ. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 2004; 96: 54653.
  • 12
    Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, Hankinson SE, Giovannucci E. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2005; 14: 8505.
  • 13
    Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 1999; 91: 6205.
  • 14
    Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 2000; 9: 3459.
  • 15
    Probst-Hensch NM, Yuan J-M, Stanczyk FZ, Gao YT, Ross RK, Yu MC. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. Br J Cancer 2001; 85: 16959.
  • 16
    Palmqvist R, Hallmans G, Rinaldi S, Biessy C, Stenling R, Riboli E, Kaaks R. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut 2002; 50: 6426.
  • 17
    Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004; 363: 134653.
  • 18
    Morris JK, George LM, Wu T, Wald NJ. Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies. Br J Cancer 2006; 95: 1127.
  • 19
    Watanabe S, Tsugane S, Sobue T, Konishi M, Baba S. Study design and organization of the JPHC study. J Epidemiol 2001; 11: S3S7.
  • 20
    Tsubono Y, Kobayashi M, Sasaki S, Tsugane S. Validity and reproducibility of a self-administered food frequency questionnaire used in the baseline survey of the JPHC Study Cohort I. J Epidemiol 2003; 13: S125S133.
  • 21
    ParkinDM, WhelanSL, FerlayJ, TeppoL, ThomasDB, eds. Cancer incidence in five continents, vol. VIII (IARC Scientific Publication No. 155). Lyon: International Agency for Research on Cancer, 2002.
  • 22
    World Health Organization, FritzA, PercyC, JackA, ShanmugaratnamK, SobinL, ParkinDM, WhetanS. editors. International classification of diseases for oncology, 3rd edn. Geneva: WHO, 2000.
  • 23
    SobinLH, WittekindCh, eds (International Union Against Cancer). TNM Classification of malignant tumours, 5th edn. New York: Wiley, 1997.
  • 24
    Clayton D, Hills M. 16.5 Incidence density sampling. In: ClaytonD, HillsM. Statistical models in epidemiology. New York: Oxford University Press, 1993: 1612.
  • 25
    Mantel N. χ-Square tests with one degree of freedom; extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963; 58: 690700.
  • 26
    Noda M, Nomura T, Demura R. Evaluation of improved radioimmunoassay kit for C-peptide by Shionogi Co. Horumon to Rinsho 1997; 45: 495503. (in Japanese).
  • 27
    Martìnez ME, Giovannucci E, Spiegelman D, Hunter DJ, Willett WC, Colditz GA. Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group. J Natl Cancer Inst 1997; 89: 94855.
  • 28
    Otani T, Iwasaki M, Inoue M, Tsugane S. Body mass index, body height, and subsequent risk of colorectal cancer in middle-aged and elderly Japanese men and women: Japan public health center-based prospective study. Cancer Causes Control 2005; 16: 83950.
  • 29
    Chlebowski RT, Wactawski Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams Campbell LL, White E. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004; 350: 9911004.
  • 30
    Key TJ, Allen NE, Verkasalo PK, Banks E. Energy balance and cancer: the role of sex hormones. Proc Nutr Soc 2001; 60: 819.
  • 31
    Otani T, Iwasaki M, Yamamoto S, Sobue T, Hanaoka T, Inoue M, Tsugane S. Alcohol consumption, smoking, and subsequent risk of colorectal cancer in middle-aged and elderly Japanese men and women: Japan public health center-based prospective study. Cancer Epidemiol Biomarkers Prev 2003; 12: 1492500.
  • 32
    Hasegawa Y, Fujii K, Yamada M, Igarashi Y, Tachibana K, Tanaka T, Onigata K, Nishi Y, Kato S, Hasegawa T. Identification of novel human GH-1 gene polymorphisms that are associated with growth hormone secretion and height. J Clin Endocrinol Metab 2000; 85: 12905.
  • 33
    Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 1995; 122: 32734.
  • 34
    MacInnis RJ, English DR, Hopper JL, Haydon AM, Gertig DM, Giles GG. Body size and composition and colon cancer risk in men. Cancer Epidemiol Biomarkers Prev 2004; 13: 5539.
  • 35
    Le Marchand L, Donlon T, Seifried A, Kaaks R, Rinaldi S, Wilkens LR. Association of a common polymorphism in the human GH1 gene with colorectal neoplasia. J Natl Cancer Inst 2002; 94: 45460.
  • 36
    Zhang W, Thornton WH, MacDonald RS. Insulin-like growth factor-I and II receptor expression in rat colon mucosa are affected by dietary lipid intake. J Nutr 1998; 128: 15865.
  • 37
    Matsuda K, Oka Y. C-peptide (CPR). Nippon Rinsho 1999; 57( Suppl): 31316 (in Japanese).
  • 38
    Hizuka N. Insulin like growth factor-I and II. Nippon Rinsho 1999; 57( Suppl): 1618 (in Japanese).
  • 39
    Nakai T. Insulin-like growth factor binding protein-3 (IGFBP-3). Nippon Rinsho 1999; 57( Suppl): 1921 (in Japanese).